ENTITY

BioAge Labs (BIOA US)

4
Analysis
Health Care • United States
BioAge Labs, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. BioAge Labs serves customers worldwide.
more
Exchange Announcement • 03 Oct 2026 04:15

Current Report (Form 8-K | Period ending 2026-10-02)

Exchange Announcement • 06 Aug 2026 05:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 06 Aug 2026 04:55

Current Report (Form 8-K | Period ending 2026-08-05)

Exchange Announcement • 12 Jun 2026 20:00

Current Report (Form 8-K | Period ending 2026-06-10)

Exchange Announcement • 08 May 2026 21:10

Current Report (Form 8-K | Period ending 2026-05-08)

x